KERX Related Analyst Comments

Mar 12, 2013 02:39 PM Brean Reiterates Buy on Keryx Biopharmaceuticals (KERX)

Feb 4, 2013 02:33 PM Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'

Jan 29, 2013 08:42 AM Oppenheimer Lifs PT on Keryx Biopharmaceuticals (KERX) to $11

Jan 29, 2013 08:37 AM Stifel Nicolaus Boosts Keryx Biopharmaceuticals (KERX) PT to $13

Jan 29, 2013 08:04 AM Burrill Lifts PT on Keryx Biopharmaceuticals (KERX) to $11

Jan 28, 2013 12:48 PM Keryx Biopharmaceuticals (KERX) Gets Another 'Going to $15' Call

Jan 28, 2013 11:27 AM Roth Capital Doubles PT on Keryx (KERX); Sees Another 200% Upside

Sep 5, 2012 09:31 AM Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Generic Renagel/Renvela Gains Clarity

Jun 22, 2012 10:46 AM Oppenheimer Maintains an 'Outperform' on Keryx Biopharmaceuticals (KERX); Opportunities for Zerenex

Jun 11, 2012 08:54 AM Oppenheimer Positive on Keryx Biopharm. (KERX), Says Market Undervaluing Zerenex

Apr 5, 2012 09:04 AM Oppenheimer Defends Keryx Biopharmaceuticals (KERX), Says Sell-Off Overdone

Apr 2, 2012 11:09 AM Brean Murray Maintains 'Buy' on Keryx (KERX); Focus Shifts to Less Risky Zerenex

Apr 5, 2010 03:18 PM Canaccord Adams Maintains a 'Speculative Buy'on AEterna Zentaris (AEZS); Positive FDA Data From Partner Keryx Pharmaceuticals (KERX)

Sep 23, 2009 12:57 PM Brean Murray Ups Keryx (KERX) Target to $5 Following Zerenex OLE Trial Results

May 24, 2006 08:39 AM JP Morgan removes Keryx Biopharma (Nasdaq: KERX) from its Focus List

May 25, 2005 07:26 AM JP Morgan Starts KERX at Overweight; Adds to Focus List